Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Prepaid Assets: 2022-2025

Historic Prepaid Assets for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to $12.3 million.

  • Centessa Pharmaceuticals' Prepaid Assets fell 22.32% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year decrease of 22.32%. This contributed to the annual value of $10.5 million for FY2024, which is 49.51% down from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' Prepaid Assets stood at $12.3 million, which was up 38.11% from $8.9 million recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Prepaid Assets high stood at $22.7 million for Q3 2023, and its period low was $8.9 million during Q2 2025.
  • For the 3-year period, Centessa Pharmaceuticals' Prepaid Assets averaged around $16.3 million, with its median value being $17.8 million (2023).
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 85.89% in 2023, then slumped by 52.38% in 2025.
  • Centessa Pharmaceuticals' Prepaid Assets (Quarterly) stood at $19.9 million in 2022, then increased by 3.95% to $20.7 million in 2023, then crashed by 49.51% to $10.5 million in 2024, then declined by 22.32% to $12.3 million in 2025.
  • Its Prepaid Assets was $12.3 million in Q3 2025, compared to $8.9 million in Q2 2025 and $13.6 million in Q1 2025.